UNSPSC 51111656: Tegafur

This classification denotes a thymidylate synthase inhibitor and pyrimidine antagonist with the molecular formula C8H9FN2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1548R74NSZ, chemically known as 2,4(1h,3h)-pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)-, (r)- but generally known as tegafur, which bears US NIH Compound Identifier 5386. European Medicines Agency schedules Tegafur in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10870MIG.

UNSPSC 51111656 Tegafur is a Commodity code representing a specific pharmaceutical ingredient — tegafur, a fluoropyrimidine antineoplastic agent used in cancer treatment formulations. State and local governments procure tegafur primarily through institutional healthcare systems, correctional health services, and public health departments that operate or contract for inpatient and outpatient oncology programs. Purchasing bodies include state departments of corrections, county hospital systems, municipal health authorities, and independent school districts with on-site medical clinics. Tegafur procurement is typically bundled within larger pharmaceutical supply contracts or specialty oncology drug agreements, often sourced through group purchasing organizations (GPOs) or state pharmaceutical cooperative purchasing vehicles that negotiate volume pricing and ensure compliance with formulary requirements and FDA-approved manufacturing standards.

The source contains no recent state and local contract opportunities tagged to this code.